Tag: Tricyclic antidepressant (secondary amine activating)

  • Protriptyline

    Tricyclic antidepressant (secondary amine, activating)

    A secondary amine TCA distinguished by activating rather than sedating subjective profile; useful in depression with hypersomnia.

    Abstract

    Protriptyline (N-methyl-3-(5H-dibenzo[a,d]cyclohepten-5-yl)propan-1-amine; CAS 438-60-8; molecular formula C19H21N; molecular weight 263.38) is a secondary amine TCA approved by the FDA in 1967 under the trade name Vivactil. Distinct among TCAs for an activating subjective profile that contrasts with the sedation typical of the class; the activating profile is attributed to relatively higher NET-to-SERT selectivity and reduced H1 antagonism. NET Ki approximately 1.4 nM, SERT Ki approximately 20 nM. Plasma half-life is exceptionally long (54 to 92 hours) owing to slow CYP2D6 metabolism. The activating profile makes protriptyline a niche choice for depression with prominent hypersomnia or fatigue, including narcolepsy-associated depression where the wakefulness-promoting effect is therapeutic. Off-target activity is otherwise typical of secondary amine TCAs: muscarinic, mild H1, alpha-1, and sodium channel block. Approved for major depressive disorder; rarely first-line today owing to TCA-class limitations. Used as a reference compound for activating TCA pharmacology and in narcolepsy-related comorbidity research.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.